Acral lentiginous melanoma: Incidence and survival patterns in the United States, 1986-2005

Archives of Dermatology

Volumn 145, Issue 4, 2009, Pages 427-434

  Bradford, Portia T ^a   Goldstein, Alisa M ^a   McMaster, Mary L ^a   Tucker, Margaret A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRAL LENTIGINOUS MELANOMA; ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; CANCER CENTER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PACIFIC ISLANDER; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SKIN COLOR; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; EXTREMITIES; FEMALE; HISPANIC AMERICANS; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; UNITED STATES; YOUNG ADULT;

EID: 65349177128     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2008.609     Document Type: Article

References (39)

1. American Cancer Society. Cancer Facts & Figures 2008. Atlanta, GA: American Cancer Society; 2008.
2. Surveillance, Epidemiology, and End Results (SEER) Program: SEER*Stat Database. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, Web site, www.seer.cancer.gov. Accessed: July 2008.
3. Markovic SN, Erickson LA, Rao RD, et al; Melanoma Study Group of the Mayo Clinic Cancer Center. Malignant melanoma in the 21st Century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007; 82(3):364-380.
4. Reed RJ. New Concepts in Surgical Pathology of the Skin. New York, NY: John Wiley & Sons; 1976:89-90.
5. Arrington JH III, Reed RJ, Ichinose H, Krementz ET. Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma. Am J Surg Pathol. 1977;1(2):131-143.
6. Rippey JJ, Lewin JR. Acral lentiginous melanoma or Hutchinson's melanotic freckle of the extremities. S Afr Med J. 1978;53(26):1076-1077.
7. Coleman WP, Philip RL, Reed RR, Krementz ET. Acral lentiginous melanoma. Arch Dermatol. 1980;116(7):773-776.
8. Feibleman CE, Stoll H, Maize JC. Melanomas of the palm, sole, and nailbed: a clinicopathologic study. Cancer. 1980;46(11):2492-2504.
9. Kuchelmeister C, Schaumburg-Lever G, Garbe C. Acral cutaneous melanoma in Caucasians: clinical features, histopathology and prognosis in 112 patients. Br J Dermatol. 2000;143(2):275-280.
10. Paladugu RR, Winberg CD, Yonemoto RH. Acral lentiginous melanoma: a clinicopathologic study of 36 patients. Cancer. 1983;52(1 ):161-168.
11. Jimbow K, Takahasi H,Miura S, Ikeda S, Kukita A. Biological behavior and natural course of acral malignant melanoma: clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanoma. Am J Dermatopathol. 1984;6(1)(suppl):43-53.
12. Cormier JN, Xing Y, Ding M, et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med. 2006;166(17):1907-1914.
13. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL Jr, Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008;26(1):66-75.
14. Cockburn MG, Zadnick J, Deapen D. Developing epidemic of melanoma in the Hispanic population of California. Cancer. 2006;106(5):1162-1168.
15. Percy C, Fritz A, Ries L, eds. Conversion of Neoplasms by Topography and Morphology From the International Classification of Diseases for Oncology, Second Edition (ICD-0-2) to the International Classification of Diseases for Oncology, Third Edition (ICD-0-3). Bethesda, MD: Cancer Statistics Branch, DCCPS, Surveillance, Epidemiology and End Results Program, National Cancer Institute; 2001.
16. US Census Bureau home page, http://www.census.gov/. Accessed July 2008.
17. *Stat software, version 6.3.5. www.seer.cancer.gov/seerstat. Accessed July 2008.
18. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172(5):902-908.
19. Markovic SN, Erickson LA, Rao RD.et al; Melanoma Study Group of Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc. 2007;82(4):490-513.
20. Balch CM, Soong SJ, Gershenwalk JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001 ;19(16):3622-3634.
21. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001; 19(16):3635-3648.
22. Gimotty PA, Botbyl J, Soong SH, Guerry D. A population-based validation of the American Joint Committee on Cancer Melanoma staging system. J Clin Oncol. 2005;23(31):8065-8075.
23. Fay MP,Tiwari RC, FeuerEJ,Zou Z. Estimating average annual percent change for disease rates without assuming constant change. Biometrics. 2006;62(3): 847-854.
24. Ridgeway CA, Hieken TJ, Ronan SG, Kim DK, Gupta TK. Acral lentiginous melanoma. Arch Surg. 1995;130(1):88-92.
25. Slingluff CL Jr, Vollmer R, Seigler HF. Acral melanoma: a review of 185 patients with identification of prognostic variables. J Surg Oncol. 1990;45(2):91-98.
26. Phan A, Touzet S, Dalle S, Ronger-Salve S, Balme B, Thomas L. Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Br J Dermatol. 2006; 155(3):561-569.
27. Shah JP, Goldsmith HS. Malignant melanoma in the North American Negro. Surg Gynecol Obstet. 1971 ;133(3) :437-439.
28. Rippey JJ, Schmanan A. Skin tumors of Africans. In: Marshall J, ed. Essays on Tropical Dermatology. Amsterdam, the Netherlands: Excerpta Medica; 1972:98-115.
29. Kaplan I, Youngleson J. Malignant melanomas in the South African Bantu. Br J Plast Surg. 1972;25(1):65-68.
30. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135-2147.
31. Maldonado JL, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 2003;95(24):1878-1880.
32. Viros A, Fridlyand J, Bauer J, et al. Improving melanoma classification by integrating genetic and morphologic features. PLoS Med. 2008;5(6):e120.
33. Muchemwa FC, Ma D, Inoue Y, et al. Constitutive activation of the phosphatidyl inositol 3 kinase signaling pathway in acral lentiginous melanoma. Br J Dermatol. 2008;158(2):411-413.
34. Bastian BC, Kashani-Sabet M, Hamm H, et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res. 2000;60(7):1968-1973.
35. Scoggins CR, Ross Ml, Reintgen DS, et al. Gender-related differences in outcome for melanoma patients. Ann Surg. 2006;243(5):693-700.
36. Lasithiotakis K, Leiter U, Meier F, et al. Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer. 2008; 112(8)1795-1804.
37. Cascinelli N, Zurrida S, Galimberti V, et al. Acral lentiginous melanoma: a histological type without prognostic significance. J Dermatol Surg Oncol. 1994; 20(12):817-822.
38. Leffall LD. In discussion of: Krementz ET, Sutherland CM, Carter RD, Ryan RF. Malignant melanoma in the American black. Ann Surg. 1976;183(5):533-542.
39. Demierre MF, Chung C, Miller DR, Geller AC. Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol. 2005; 141(6):745-750.